Improved survival in the Danish center-treated cystic fibrosis patients: Results of aggressive treatment

Pediatric Pulmonology

Volumn 21, Issue 3, 1996, Pages 153-158

  Frederiksen, Birgitte ^a,b   Lanng, Susanne ^a,b   Koch, Christian ^a,b   Høiby, Niels ^a,b  

^a Pediatric Pulmonary Service   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

age at diagnosis; Cystic fibrosis; mortality rates; survival rates; treatment

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CYSTIC FIBROSIS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; MORTALITY; PRIORITY JOURNAL; PROBABILITY; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DENMARK; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIFE TABLES; MALE; PSEUDOMONAS INFECTIONS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0029921514     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R     Document Type: Article

References (27)

1. Corey M, McLaughlin J, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988; 41: 583-591.
2. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993; 122:1-9.
3. Cystic Fibrosis Foundation, Patient Registry 1992 Annual Data Report, Bethesda, Maryland, October 1993.
4. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: Current survival and population estimates to the year 2000. Thorax. 1991; 46: 881-885.
5. Nielsen OH, Schiøtz PO. Cystic fibrosis in Denmark in the period 1945-1981. Evaluation of centralised treatment. Acta Paediatr Scand. 1982; (suppl 301):107-119.
6. Høiby N, Friis B, Jensen K, Koch C, Møller NE, Støvring S, Szaff M. Antimicrobial chemotherapy in cystic fibrosis patients. Acta Paediatr Scand. 1982; (Suppl 301):75-100.
7. Szaff M, Høiby N, Flensborg EW. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand. 1983; 72:651-657.
8. Pedersen SS, Jensen T, Høiby N, Koch C, Flensborg EW. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr Scand. 1983; 72:651-657.
9. Valerius NH, Koch C, Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet. 1991; 338:725-726.
10. Schwartz M, Johansen HK, Koch C, Brandt NJ. Frequency of the ΔF508 mutation on cystic fibrosis chromosomes in Denmark. Hum Genet. 1992; 85:427-428.
11. Warwick WJ, Pogue RE, Gerber HU, Nesbitt CJ. Survival patterns in cystic fibrosis. J Chron Dis. 1975; 28:609-622.
12. Clayton D, Hills M. Statistical Models in Epidemiology, 1st ed. Oxford: Oxford Science. 1993:46-48.
13. Schwanz M, Brandt NJ, Skovby F. Screening for carriers of cystic fibrosis among pregnant women: A pilot study. Eur J Hum Genet. 1993; 1:239-244.
14. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992; 326:1187-1191.
15. Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D. Russell G, Jackson AD, Bentley B. Cystic fibrosis in the United Kingdom, 1968-1988: Incidence, population and survival. Paediatr Perinat Epidemiol. 1993; 7:157-166.
16. Johansen HK, Nir M, Høiby N, Koch C, Schwartz M. Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation. Lancet. 1991; 337:631-634.
17. Tizzano EF, Buchwald M. Cystic fibrosis: Beyond the gene to therapy. J Pediatr. 1992; 120:337-349.
18. Høiby N, Pedersen SS. Estimated risk of cross-infection in Danish cystic fibrosis patients. Acta Paediatr Scand. 1989; 78:395-404.
19. Nir M, Johansen HK, Høiby N. Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients. Acta Paediatr Scand. 1992; 81:1042-1043.
20. Pedersen SS, Koch C, Høiby N, Rosendal K. An epidemic spread multiresistant Pseudomonas aeruginosa in a cystic fibrosis center. J Antimicrob Chemother. 1986; 17:505-516.
21. Jensen T, Pedersen SS, Game S, Heilmann C, Høiby N, Koch C. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother. 1987; 19:831-838.
22. Jensen T, Pedersen SS, Nielsen CH, Høiby N, Koch C. The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis. J Antimicrob Chemother. 1987; 20:585-594.
23. Lanng S, Thorsteinsson B, Erichsen G, Nerup J, Koch C. Glucose tolerance in cystic fibrosis. Arch Dis Child. 1991; 66:612-616.
24. Finkelstein SM, Wielinski CL, Elliot GR, Warwick WJ, Barbosa J, Wu S, Klein DJ. Diabetes mellitus associated with cystic fibrosis. J Pediatr. 1988; 112:373-377.
25. Reisman J, Corey M, Canny G, Levison H. Diabetes mellitus in patients with cystic fibrosis: Effect on survival. Pediatrics. 1990; 86:374-377.
26. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr. 1992; 151:684-687.
27. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: Effect of insulin therapy on clinical status. Acta Paediatr Scand. 1994; 83:849-853.